Form D · Other Health Care
Aerami Therapeutics Holdings, Inc.
Durham, NC · CIK 0001650840
Offering snapshot reported Nov 22, 2023 · SEC filing
- Reported sold
- $1.02M Offering amount: $20M
- Investors reported
- 30 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 9, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 22, 2023 | Initial | $1,016,000 | No comparison | 30 | SEC filing |
| Dec 16, 2022 | Initial | $5,380,000 | No comparison | 39 | SEC filing |
| Nov 4, 2021 | Amendment | $22,250,560 | $20,050,560vs Sep 23, 2021 | 238 | SEC filing |
| Sep 23, 2021 | Initial | $2,200,000 | No comparison | 28 | SEC filing |
| Jun 17, 2020 | Initial | $4,608,000 | No comparison | 61 | SEC filing |
| Jun 11, 2019 | Amendment | $21,046,000 | $0vs Jun 10, 2019 | 283 | SEC filing |
| Jun 10, 2019 | Initial | $21,046,000 | No comparison | 283 | SEC filing |
| Jan 11, 2018 | Amendment | $19,033,459 | $4,337,055vs Dec 18, 2017 | 135 | SEC filing |
| Dec 18, 2017 | Initial | $14,696,404 | No comparison | 100 | SEC filing |
| Jun 26, 2017 | Amendment | $3,424,404 | $2,586,800vs Apr 26, 2017 | 49 | SEC filing |
| Apr 26, 2017 | Initial | $837,604 | No comparison | 5 | SEC filing |
| Aug 4, 2016 | Initial | $625,000 | No comparison | 2 | SEC filing |
| Oct 2, 2015 | Initial | $10,134,033 | No comparison | 135 | SEC filing |
Offering details
- Securities
- Debt, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $94K
- Finders' fees
- $0
- Form D file number
- 021-498010
The maximum offering amount is $10,000,000. If the offering is oversubscribed issuer and placement agent may at their mutual discretion have the issuer offer up to an additional $10,000,000 principal amount. The note offering will last until 1/3/2024.
The placement agent will also be issued warrants to purchase up to 10% of the number of shares of capital stock issuable upon the conversion of the Notes following the final closing of the note offering.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Aegis Capital Corp. | 15007 |
Source: Form D, filed Nov 22, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| K Jeffrey Bell | Executive |
| Gary C. Burgess | Executive |
| Augustine P.Y. Chow, M.D. | Director |
| Timm Crowder | Executive |
| Darlene Deptula Hicks | Director, Executive |
| Barry Deutsch | Executive |
| Donald D. Huffman | Director, Executive |
| Matt Jennings | Director |
| Mike Kaseta | Executive |
| Michael J. Kaseta | Executive |
| Kenneth B. Lee, Jr. | Director |
| Tyler Martin, M.D. | Director, Executive |
| John S. Patton | Director |
| John S. Patton, Ph.D | Director, Executive |
| Lisa E. Porter, M.D. | Executive |
| Dr. Melissa Rhodes | Executive |
| Adam K. Stern | Director |
| Steven Thornton | Director |
| Steve Thornton | Director, Executive |
| Bill Welch | Director |
| William Patrick Welch | Director |
| Anne C. Whitaker | Director, Executive |
| Benjamin Wolin | Director |
| Ben Wolin | Director |
| Vivian Yan | Director |
| Lisa Yanez | Executive |
| Greg S. Zante | Executive |
| Joshua Ziel | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
600 Park Offices Dr. Ste. 300
Durham, NC, 27709
Phone: 919-797-9792
Durham, NC, 27709
Phone: 919-797-9792